Table 10.

The results of QoL assessment (EORTC QLQ-C30 symptom scales) in patient groups differing with respect to illness perception and the results of the analysis of variance.

QLQ-C30 Symptom Scales	Illness Perception (MEDIS)			ANOVA p
	Positive 0–68 pts.	Neutral 69–94 pts.	Negative 95–140 pts.
	n = 69	n = 68	n = 65
Fatigue (FA)				0.003
M ± SD	33.2 ± 22.5	40.8 ± 22.0	45.8 ± 19.7
Me (Q1; Q3)	33 [22; 33]	33 [31; 56]	44 [33; 56]
Min–Max	0–100	0–100	11–89
Nausea and vomiting (NV)				<0.001
M ± SD	8.2 ± 19.9	7.4 ± 17.1	29.5 ± 32.6
Me (Q1; Q3)	0 [0; 0]	0 [0; 0]	17 [0; 50]
Min–Max	0–100	0–100	0–100
Pain (PA)				<0.001
M ± SD	21.7 ± 25.0	24.5 ± 21.3	39.2 ± 26.1
Me (Q1; Q3)	17 [0; 33]	17 [0; 33]	33 [17; 67]
Min–Max	0–100	0–67	0–100
Dyspnoea (DY)				0.028
M ± SD	12.1 ± 22.1	10.3 ± 21.7	21.4 ± 31.1
Me (Q1; Q3)	0 [0; 33]	0 [0; 0]	0 [0; 33]
Min–Max	0–100	0–100	0–100
Sleep disturbance (SL)				0.045
M ± SD	38.2 ± 35.4	34.8 ± 35.0	48.7 ± 28.3
Me (Q1; Q3)	33 [0; 67]	33 [0; 67]	33 [33; 67]
Min–Max	0–100	0–100	0–100
Appetite loss (AP)				<0.001
M ± SD	14.5 ± 24.6	14.7 ± 21.1	33.8 ± 33.1
Me (Q1; Q3)	0 [0; 33]	0 [0; 33]	33 [0; 67]
Min–Max	0–100	0–67	0–100
Constipation (CO)				0.002
M ± SD	15.0 ± 22.5	18.6 ± 24.7	29.2 ± 25.3
Me (Q1; Q3)	0 [0; 33]	0 [0; 33]	33 [0; 33]
Min–Max	0–100	0–100	0–100
Diarrhoea (DI)				0.002
M ± SD	5.8 ± 16.1	8.3 ± 21.8	19.0 ± 27.6
Me (Q1; Q3)	0 [0; 0]	0 [0; 0]	0 [0; 33]
Min–Max	0–100	0–100	0–100
Financial difficulties (FI)				<0.001
M ± SD	20.6 ± 28.2	24.0 ± 25.0	46.2 ± 30.4
Me (Q1; Q3)	0 [0; 33]	33 [0; 33]	33 [33; 67]
Min–Max	0–100	0–100	0–100

M—mean; SD—standard deviation; Me—median; Q₁—lower quartile; Q₃—upper quartile; Min—lowest value; Max—highest value; n—number; values in bold indicate statistical significance (p < 0.05).